BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23894154)

  • 1. Genome-wide association study on differentiated thyroid cancer.
    Köhler A; Chen B; Gemignani F; Elisei R; Romei C; Figlioli G; Cipollini M; Cristaudo A; Bambi F; Hoffmann P; Herms S; Kalemba M; Kula D; Harris S; Broderick P; Houlston R; Pastor S; Marcos R; Velázquez A; Jarzab B; Hemminki K; Landi S; Försti A
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1674-81. PubMed ID: 23894154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
    Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
    Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
    Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
    Kulkarni O; Sugier PE; Guibon J; Boland-Augé A; Lonjou C; Bacq-Daian D; Olaso R; Rubino C; Souchard V; Rachedi F; Lence-Anta JJ; Ortiz RM; Xhaard C; Laurent-Puig P; Mulot C; Guizard AV; Schvartz C; Boutron-Ruault MC; Ostroumova E; Kesminiene A; Deleuze JF; Guénel P; De Vathaire F; Truong T; Lesueur F
    Sci Rep; 2021 Apr; 11(1):8932. PubMed ID: 33903625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.
    Son HY; Hwangbo Y; Yoo SK; Im SW; Yang SD; Kwak SJ; Park MS; Kwak SH; Cho SW; Ryu JS; Kim J; Jung YS; Kim TH; Kim SJ; Lee KE; Park DJ; Cho NH; Sung J; Seo JS; Lee EK; Park YJ; Kim JI
    Nat Commun; 2017 Jul; 8():15966. PubMed ID: 28703219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
    Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
    J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.
    Mancikova V; Cruz R; Inglada-Pérez L; Fernández-Rozadilla C; Landa I; Cameselle-Teijeiro J; Celeiro C; Pastor S; Velázquez A; Marcos R; Andía V; Álvarez-Escolá C; Meoro A; Schiavi F; Opocher G; Quintela I; Ansede-Bermejo J; Ruiz-Ponte C; Santisteban P; Robledo M; Carracedo A
    Int J Cancer; 2015 Oct; 137(8):1870-8. PubMed ID: 25855579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.
    Figlioli G; Chen B; Elisei R; Romei C; Campo C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Gemignani F; Försti A
    Sci Rep; 2015 Mar; 5():8922. PubMed ID: 25753578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma.
    Figlioli G; Elisei R; Romei C; Melaiu O; Cipollini M; Bambi F; Chen B; Köhler A; Cristaudo A; Hemminki K; Gemignani F; Försti A; Landi S
    Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):700-13. PubMed ID: 26843521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
    Truong T; Lesueur F; Sugier PE; Guibon J; Xhaard C; Karimi M; Kulkarni O; Lucotte EA; Bacq-Daian D; Boland-Auge A; Mulot C; Laurent-Puig P; Schvartz C; Guizard AV; Ren Y; Adjadj E; Rachédi F; Borson-Chazot F; Ortiz RM; Lence-Anta JJ; Pereda CM; Comiskey DF; He H; Liyanarachchi S; de la Chapelle A; Elisei R; Gemignani F; Thomsen H; Forsti A; Herzig AF; Leutenegger AL; Rubino C; Ostroumova E; Kesminiene A; Boutron-Ruault MC; Deleuze JF; Guénel P; de Vathaire F
    Int J Cancer; 2021 Jun; 148(12):2935-2946. PubMed ID: 33527407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.
    Pereda CM; Lesueur F; Pertesi M; Robinot N; Lence-Anta JJ; Turcios S; Velasco M; Chappe M; Infante I; Bustillo M; García A; Clero E; Xhaard C; Ren Y; Maillard S; Damiola F; Rubino C; Salazar S; Rodriguez R; Ortiz RM; de Vathaire F
    BMC Genet; 2015 Mar; 16():22. PubMed ID: 25879635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.
    Rogounovitch TI; Bychkov A; Takahashi M; Mitsutake N; Nakashima M; Nikitski AV; Hayashi T; Hirokawa M; Ishigaki K; Shigematsu K; Bogdanova T; Matsuse M; Nishihara E; Minami S; Yamanouchi K; Ito M; Kawaguchi T; Kondo H; Takamura N; Ito Y; Miyauchi A; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2015 Mar; 25(3):333-40. PubMed ID: 25562676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.
    Cipollini M; Figlioli G; Garritano S; Bramante S; Maiorano L; Gnudi F; Cecchini A; De Paola F; Damicis L; Frixa T; Landi D; Cancemi L; De Santi C; Melaiu O; Foddis R; Cristaudo A; Bonotti A; Romei C; Elisei R; Pellegrini G; Barale R; Gemignani F; Landi S
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2121-5. PubMed ID: 24008490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
    Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
    PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.
    Guibon J; Sugier PE; Kulkarni O; Karimi M; Bacq-Daian D; Besse C; Boland A; Adjadj E; Rachédi F; Rubino C; Xhaard C; Mulot C; Laurent-Puig P; Guizard AV; Schvartz C; Ortiz RM; Ren Y; Ostroumova E; Deleuze JF; Boutron-Ruault MC; Kesminiene A; De Vathaire F; Guénel P; Lesueur F; Truong T
    Oncotarget; 2021 Mar; 12(5):493-506. PubMed ID: 33747362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
    Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis.
    Sturgis EM; Zhao C; Zheng R; Wei Q
    Laryngoscope; 2005 Jun; 115(6):938-45. PubMed ID: 15933498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
    Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
    Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of GWAS variants associated with differentiated thyroid cancer.
    Jendrzejewski JP; Sworczak K; Comiskey DF; de la Chapelle A
    Endokrynol Pol; 2019; 70(5):423-429. PubMed ID: 31681970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXE1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
    Ren Y; Lence-Anta JJ; Pereda CM; Chappe M; Velasco M; Infante I; Bustillo M; Turcios S; Leufroy A; Guérin T; Noël L; Lesueur F; Maillard S; Cléro E; Xhaard C; Allodji RS; Rubino C; Rodriguez R; Ortiz RM; de Vathaire F
    Thyroid; 2016 Dec; 26(12):1752-1760. PubMed ID: 27610545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.